2012 IW US 500 Company Profile

Eli Lilly & Co. LLY NYS
Pharmaceuticals
Indianapolis, Indiana
2012 IW US 500 Rank:
Current Rank : 50
Prior Rank : 48
Executive 1 : John C. Lechleiter, Chairman, President,
Executive 2 : Derica W. Rice, Executive Vice President, Chief Financial Officer,
50 of 500
2011 Revenue (US$ Millions)$24,287
2010 Revenue (US$ Millions)$23,076
Revenue Growth (%)5.25%
Net Income (US$ Millions)$4,348
Common Shares Outstanding (Millions)1,157.79
Earnings Per Share (US$)$3.90
Earnings Per Share Growth (%)(14.85%)
Price To Earnings Ratio10.71
Total Equity (US$ Millions)$13,542
Profit Growth (%)(14.24%)
Profit Margin (%)17.9%
Return On Equity (%)35%
Long Term Debt (US$ Millions)$5,465
Debt To Equity Ratio (%)0.4%
Market Capitalization (US$ Millions)$48,118
Total Assets (US$ Millions)$33,660
Return on Assets (%)14.02%
Current Assets (US$ Millions)$14,248
Inventories (US$ Millions)$2,300
Current Liabilities (US$ Millions)$8,931
Cost of Goods Sold (US$ Millions)$5,068
Asset Turnover0.72
Inventory Turnover2.1

Subscribe to IW Newsletters

IW Marketplace - Buy a Link Now